Stiff skin syndrome

Stiff skin syndrome (SSS), also known as congenital fascial dystrophy, is an extremely rare genetic connective tissue disorder characterized by hard, thick skin that is bound tightly to underlying tissues, resulting in severe limitation of joint mobility. The condition typically presents in infancy or early childhood with rock-hard, stony induration of the skin, particularly over the buttocks and thighs, though it can extend to involve the entire body. Affected individuals develop progressive joint contractures (especially of the hips, knees, and shoulders) due to the taut, inelastic skin, which significantly restricts movement and growth. The skin cannot be pinched or folded normally. Mild hypertrichosis (excessive hair growth) over affected areas is commonly observed. Stiff skin syndrome is caused by heterozygous mutations in the FBN1 gene (encoding fibrillin-1), the same gene implicated in Marfan syndrome, though the specific mutations and resulting phenotype are distinct. The FBN1 mutations in SSS lead to excessive microfibril deposition and aberrant transforming growth factor-beta (TGF-β) signaling in the dermis and fascia. Unlike scleroderma, which it may superficially resemble, SSS does not involve internal organ fibrosis, Raynaud phenomenon, or autoimmune features. Histological examination of the skin reveals thickened dermis with increased collagen deposition and accumulation of mucin. There is currently no cure for stiff skin syndrome. Treatment is primarily supportive and symptomatic, focusing on physical therapy and rehabilitation to maintain joint mobility and prevent further contractures. Surgical release of contractures may be considered in some cases but has limited long-term success. Research into TGF-β pathway modulation (such as losartan) has shown promise in preclinical models, but no established pharmacological therapy exists for patients at this time. Early diagnosis and multidisciplinary management involving dermatology, orthopedics, and genetics are important for optimizing outcomes.

Common questions about Stiff skin syndrome